BDNF and major depressive disorder: In MDD, hypermethylation of BDNF promoters, especially exon IV, reduces BDNF expression and impairs neuroplasticity whereas hypermethylation of the NR3C1 promoter impairs hypothalamic-pituitary-adrenal (HPA)-axis regulation following childhood trauma (13, 14).